WELCOME TO THE AICARDI SYNDROME COMMUNITY: This Patient-To-Patient Community is for discussions relating to Aicardi Syndrome, which is a rare genetic disorder that primarily affects newborn girls, and is often characterized by partial or complete absence of the structure that links the two sides of the brain (corpus callosum), complex seizures and retinal lacunae which are lesions on the retina.
The official name of this gene is “5,10-methylenetetrahydrofolate reductase (NADPH).”
MTHFR is the gene's official symbol. The MTHFR gene is also known by other names, listed below.
The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Methylenetetrahydrofolate reductase is important for a chemical reaction involving forms of the vitamin folate (also called folic acid or vitamin B9). Specifically, this enzyme converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This reaction is required for the multistep process that converts the amino acid homocysteine to another amino acid, methionine. The body uses methionine to make proteins and other important compounds.
homocystinuria - caused by mutations in the MTHFR gene
At least 24 mutations in the MTHFR gene have been identified in people with homocystinuria. Most of these mutations change single amino acids in methylenetetrahydrofolate reductase. These substitutions disrupt the function of the enzyme, and may inactivate it completely. Other mutations lead to the production of an abnormally small, nonfunctional version of the enzyme. Without methylenetetrahydrofolate reductase, homocysteine cannot be converted to methionine. As a result, homocysteine builds up in the bloodstream and methionine is depleted. Some of the excess homocysteine is excreted in urine. Researchers have not determined how altered levels of homocysteine and methionine lead to the health problems associated with homocystinuria.
other disorders - increased risk from variations of the MTHFR gene
A specific version (variant) of the MTHFR gene may increase the risk of cardiovascular disease and certain kinds of birth defects. This variant is relatively common in many populations worldwide. It replaces the nucleotide cytosine with the nucleotide thymine at position 677 in the MTHFR gene (written as C677T). (Nucleotides are the building blocks of DNA.) This change in the MTHFR gene produces a form of methylenetetrahydrofolate reductase that has reduced activity at higher temperatures (thermolabile). People with the thermolabile form of the enzyme have increased levels of homocysteine in their blood.
The C677T variant has been associated with an increased risk of cardiovascular disease, including coronary heart disease and stroke, in adults. It may also play a role in the risk of high blood pressure in pregnancy (preeclampsia). Additionally, research suggests that the variant may be a risk factor for birth defects that occur during the development of the brain and spinal cord (neural tube defects). Many factors, however, play a part in determining the risk of these complex disorders.
Cytogenetic Location: 1p36.3
Molecular Location on chromosome 1: base pairs 11,769,246 to 11,788,568
The MTHFR gene is located on the short (p) arm of chromosome 1 at position 36.3.
More precisely, the MTHFR gene is located from base pair 11,769,246 to base pair 11,788,568 on chromosome 1.
What other names do people use for the MTHFR gene or gene products?
The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.